90
Participants
Start Date
December 31, 1999
Primary Completion Date
March 31, 2006
Study Completion Date
January 31, 2007
Docetaxel
Every 3 weeks at a starting dose of 75 mg/m2 IV over 1 hour on day 1, repeated every 21 days.
Docetaxel
35 mg/m2 IV over 30 minutes on days 1, 8, and 15, for 3 weeks followed by one week of rest repeated every 28 days.
MD Anderson Cancer Center at University of Texas, Houston
University of Texas M.D. Anderson CCOP Research Base, Houston
National Cancer Institute (NCI)
NIH
M.D. Anderson Cancer Center
OTHER